KLE Society's Institute of Dental Sciences   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Bengaluru India (1992)

Organization Overview

First Clinical Trial
2013
NCT03616925
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

KLE Society's Institute of Dental Sciences | KLE VK Institute of Dental Sciences

Active Ingredients

Drugs in Phase 3 Trials (3)

curcumin (1 trial)

human fibrin (Tisseel) (1 trial)

platelet rich fibrin (2 trials)

Drugs in Phase 1 Trials (1)

peripheral blood mesenchymal stem cells (1 trial)

Drugs in Other Trials (2)

chlorhexidine (hibitane) (1 trial)

mulberry leaf extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 3)

Periodontitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 6